No Data
*ST Jingfeng: Report for the third quarter of 2024
*ST Jingfeng (000908.SZ): Intends to carry out commissioned research and development.
Gelonghui, October 18th | *ST Jingfeng (000908.SZ) announced that, according to the development needs, the company and its holding subsidiaries plan to engage in related-party entrusted research and development with the subsidiary of the related party CSPC Pharma Holdings Co., Ltd. (referred to as "CSPC Pharma Group"), named CSPC Pharma Group Zhongqi Pharmaceutical Technology (Shijiazhuang) Co., Ltd. (referred to as "CSPC Zhongqi"), with a total expected transaction amount not exceeding 10 million yuan. The above limit is valid for three years from the date of approval by the board of directors.
ST Jingfeng (000908.SZ) subsidiary Shanghai Jingfeng plans to sell its property located in Suzhou city at a price of 64.6928 million yuan.
*ST Jingfeng (000908.SZ) announced that its wholly-owned subsidiary shanghai Jingfeng Pharmaceutical Co., Ltd. (referred to as "shanghai...
*ST Jingfeng (000908.SZ): Shareholder Ye Xiangwu completed a shareholding of 1.0448 million shares
On September 24, Gelunhui reported that Special Treat Jingfeng (000908.SZ) announced that the company recently received a notice from Mr. Ye Xiangwu regarding the completion of the shareholding plan of Hunan Jingfeng Pharmaceutical Co., Ltd. As of the disclosure date of the announcement, Mr. Ye Xiangwu has cumulatively increased the company's shareholding by 1.0448 million shares through the Shenzhen Stock Exchange trading system in a centralized bidding trading manner, accounting for 0.12% of the total share capital of the company. The total amount of the shareholding is 2,002,940 yuan (excluding transaction costs), and the shareholding amount has reached the lower limit of this shareholding plan. This shareholding plan has been completed.
*ST Jingfeng: 2024 Semi-Annual Report Summary
*ST Jingfeng: 2024 Semi-Annual Report
Even After Rising 19% This Past Week, Hunan Jingfeng PharmaceuticalLtd (SZSE:000908) Shareholders Are Still Down 49% Over the Past Five YearsNo Data
No Data
